Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2015

01-09-2015 | Original Article

The prevalence of gestational diabetes mellitus and its related risk factors in Gorgan, north of Iran. Selective or universal screening test is cost-effective?

Authors: Fatemeh Mohammadzadeh, Samira Eshghinia, Mohammad Ali Vakili

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2015

Login to get access

Abstract

Gestational diabetes mellitus (GDM) is the most prevalent metabolic disorder in pregnancy. GDM is defined in <1 % to 28 % of pregnancies, depending on the diagnostic criteria, the ethnic and racial characteristics. This study was performed to determine the prevalence of GDM and related risk factors among pregnant women in Gorgan, north of Iran. In a cross sectional study, 1276 pregnant women were recruited. All of women screened with glucose challenge test (GCT) in 24–28th wks of gestational age. Women with positive GCT underwent 100 g glucose tolerance test (OGTT). Diagnosis of GDM was according to Carpenter and Coustan’s criteria. GCT was positive in 200 women (15.8 % with CI: 13.8 %–17.8 %) and GDM was diagnosed in 62 case (4.9 % with CI:3.7 %–6.8 %). In a multiple logistic regression, risk factors such as age, BMI, history of macrosomia, familial history of diabetes and impaired fasting glucose (IFG) were identified as independent risk factors for GDM (p < 0.05). Among GDM cases, 3.2 %(2 women) had no risk factor. These results show moderate prevalence of GDM in north of Iran. It seems that a selective GDM screening method for women with some risk factors is more appropriate than general screening.
Literature
1.
go back to reference Schneider S, Bock C, Wetzel M, Maul H, Loerbroks A. The prevalence of gestational diabetes in advanced economies. J Perinat Med. 2012;12:1–10. Schneider S, Bock C, Wetzel M, Maul H, Loerbroks A. The prevalence of gestational diabetes in advanced economies. J Perinat Med. 2012;12:1–10.
2.
go back to reference Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med. 2012;25:600–10.CrossRefPubMed Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med. 2012;25:600–10.CrossRefPubMed
3.
go back to reference Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA, et al. Gestational diabetes and pregnancy outcomes: a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;31:12–23. Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA, et al. Gestational diabetes and pregnancy outcomes: a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;31:12–23.
4.
go back to reference Vääräsmäki M, Pouta A, Elliot P, Tapanainen P, Sovio U, Ruokonen A, et al. Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort. Am J Epidemiol. 2009;169:1209–15.CrossRefPubMed Vääräsmäki M, Pouta A, Elliot P, Tapanainen P, Sovio U, Ruokonen A, et al. Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort. Am J Epidemiol. 2009;169:1209–15.CrossRefPubMed
5.
go back to reference Retnakaran R, Shah BR. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med. 2009;26:474–7.CrossRefPubMed Retnakaran R, Shah BR. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med. 2009;26:474–7.CrossRefPubMed
6.
go back to reference Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–48.PubMedCentralCrossRefPubMed Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–48.PubMedCentralCrossRefPubMed
7.
go back to reference van Leeuwen M, Louwerse MD, Opmeer BC, Limpens J, Serlie MJ, Reitsma JB, et al. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG. 2012;119:393–401.CrossRefPubMed van Leeuwen M, Louwerse MD, Opmeer BC, Limpens J, Serlie MJ, Reitsma JB, et al. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG. 2012;119:393–401.CrossRefPubMed
8.
go back to reference Kitzmiller JL. Cost analysis of diagnosis and treatment of gestational diabetes mellitus. Clin Obstet Gynecol. 2000;43:140–53.CrossRefPubMed Kitzmiller JL. Cost analysis of diagnosis and treatment of gestational diabetes mellitus. Clin Obstet Gynecol. 2000;43:140–53.CrossRefPubMed
9.
go back to reference ADA (2011) Testing in Asymptomatic Patients. Diabetes Care 34 (suppl 1):S14 ADA (2011) Testing in Asymptomatic Patients. Diabetes Care 34 (suppl 1):S14
10.
go back to reference Xiong X, Saunders LD, Wang FL, Demianzuk NN. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet. 2001;75:221–8.CrossRefPubMed Xiong X, Saunders LD, Wang FL, Demianzuk NN. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet. 2001;75:221–8.CrossRefPubMed
11.
go back to reference Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–73.PubMed Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–73.PubMed
12.
go back to reference Taber LC. Gestational Diabetes: Is It Preventable? Am Jof Lifestyle Med. 2012;6:395–406.CrossRef Taber LC. Gestational Diabetes: Is It Preventable? Am Jof Lifestyle Med. 2012;6:395–406.CrossRef
13.
go back to reference Buckley BS, Harreiter J, Damm P, Corcoy R, Chico A, Simmons D, et al. Gestational diabetes mellitus in Europe: prevalence, Current screening practice and barriers to screening. A review. Diabet Med. 2012;29:844–54.CrossRefPubMed Buckley BS, Harreiter J, Damm P, Corcoy R, Chico A, Simmons D, et al. Gestational diabetes mellitus in Europe: prevalence, Current screening practice and barriers to screening. A review. Diabet Med. 2012;29:844–54.CrossRefPubMed
14.
go back to reference Berkowitz GS, Lapinski RH, Wein R, Lee D. Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol. 1992;135:965–73.PubMed Berkowitz GS, Lapinski RH, Wein R, Lee D. Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol. 1992;135:965–73.PubMed
15.
go back to reference Khoshniatnikoo M, Sh A a, Larijani B. The review of GDM prevalence in different regions of Iran. Iran J Diabetes Lipid Disorders. 2008;8:1–10. Khoshniatnikoo M, Sh A a, Larijani B. The review of GDM prevalence in different regions of Iran. Iran J Diabetes Lipid Disorders. 2008;8:1–10.
16.
go back to reference Hadaegh F, KheirAndish M, RahimiSh TM. Prevalence of gestational diabetes in pregnant women of Bandar Abbas. Iran J Endocrinol Metab. 2004;6:233–25. Hadaegh F, KheirAndish M, RahimiSh TM. Prevalence of gestational diabetes in pregnant women of Bandar Abbas. Iran J Endocrinol Metab. 2004;6:233–25.
17.
go back to reference Rahimi G. The Prevalence of Gestational Diabetes in Pregnant Women eferring to Ardabil Health Centers, 2003. J Ardabil Univ Med Sci Health Serv. 2004;4:32–8. Rahimi G. The Prevalence of Gestational Diabetes in Pregnant Women eferring to Ardabil Health Centers, 2003. J Ardabil Univ Med Sci Health Serv. 2004;4:32–8.
18.
go back to reference Tabatabaei A, Fallah Z, Haghighi S, Farmani M, Horri N, Eslamian Z, et al. Prevalence and Risk Factors for Gestational Diabetes Mellitus in Pregnant Women of Isfahan, Iran. Iran J Endocrinol Metab. 2007;9:251–9. Tabatabaei A, Fallah Z, Haghighi S, Farmani M, Horri N, Eslamian Z, et al. Prevalence and Risk Factors for Gestational Diabetes Mellitus in Pregnant Women of Isfahan, Iran. Iran J Endocrinol Metab. 2007;9:251–9.
19.
go back to reference Siribaddana SH, Deshabandu R, Rajapakse D, Silva K, Fernando DJ. The prevalence of gestational diabetes in a sri Lankan Qntenatal Clinic. Ceylon Med J. 1998;43:88–91.PubMed Siribaddana SH, Deshabandu R, Rajapakse D, Silva K, Fernando DJ. The prevalence of gestational diabetes in a sri Lankan Qntenatal Clinic. Ceylon Med J. 1998;43:88–91.PubMed
20.
go back to reference Anzaku AS, Musa J. Prevalence and associated risk factors for gestational diabetes in Jos, North-central, Nigeria. Arch GynecolObstet. 2013;287(5):859–63. Anzaku AS, Musa J. Prevalence and associated risk factors for gestational diabetes in Jos, North-central, Nigeria. Arch GynecolObstet. 2013;287(5):859–63.
21.
go back to reference Hossein-Nezhad A, Maghbooli Z, Vassigh AR, Larijani B. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol. 2007;46:236–41.CrossRefPubMed Hossein-Nezhad A, Maghbooli Z, Vassigh AR, Larijani B. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol. 2007;46:236–41.CrossRefPubMed
22.
go back to reference Keshavarz M, Cheung NW, Babaee GR, Kalalian Moghadam H, Ajami ME, Shariati M. Gestational diabetes in Iran: Incidence, risk factors and pregnancy outcomes. Diabetes Res Clin Pract. 2005;69:279–86.CrossRefPubMed Keshavarz M, Cheung NW, Babaee GR, Kalalian Moghadam H, Ajami ME, Shariati M. Gestational diabetes in Iran: Incidence, risk factors and pregnancy outcomes. Diabetes Res Clin Pract. 2005;69:279–86.CrossRefPubMed
23.
go back to reference Shahbazian HB, Shahbazian N, Yarahmadi M, Saeidi S (2012) Prevalence of Gestational Diabetes Mellitus in Pregnant Women Referring to Gynecology and Obstetrics Clinics Scientific Medical Journal of Ahwaz University of Medical Sciences 11:113–121 Shahbazian HB, Shahbazian N, Yarahmadi M, Saeidi S (2012) Prevalence of Gestational Diabetes Mellitus in Pregnant Women Referring to Gynecology and Obstetrics Clinics Scientific Medical Journal of Ahwaz University of Medical Sciences 11:113–121
Metadata
Title
The prevalence of gestational diabetes mellitus and its related risk factors in Gorgan, north of Iran. Selective or universal screening test is cost-effective?
Authors
Fatemeh Mohammadzadeh
Samira Eshghinia
Mohammad Ali Vakili
Publication date
01-09-2015
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-014-0209-8

Other articles of this Issue 3/2015

International Journal of Diabetes in Developing Countries 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine